Suboxone MDL Mostly Survives Initial Preemption Challenge
The authors write "Suboxone is the brand name of combination of Buprenorphine and Naloxone, manufactured by Indivior, Inc., and used in the treatment of opioid dependence. In January of 2022, the FDA ...
Florida Judge Tosses Antitrust Case Over Yacht Broker Commissions
In a Tuesday ruling, U.S. District Judge K. Michael Moore concluded that, despite similarities to antitrust litigation ...
JD Supra5d
Regulating Automotive Emissions: Part IV - Emissions Litigation To Watch
With several pending litigations challenging federal emissions and fuel economy standards, the automotive industry is likely to see ...